GlassScriptPhysician profile
Michael B Shapiro
NPI 1669455044
$70,979.13
in general payments reported to CMS, 2019-2025
18 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $6,655 · 2021: $8,881 · 2022: $231 · 2023: $436 · 2024: $345 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $69,591.64 | 2019-2022 | |
| Abbvie INC. | $352.87 | 2022-2025 | Durysta, Lumigan |
| Alcon Vision LLC | $296.68 | 2019-2025 | Clareon Panoptix Pro, Argos, Hydrus Microstent |
| Rayner Intraocular Lenses Limited | $129.19 | 2022-2024 | Rayone Emv, Omidria, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $117.93 | 2023-2025 | Miebo, Envista Envy Iol |
| Omeros Corporation | $94.03 | 2019-2021 | |
| Oyster Point Pharma, INC. | $72.27 | 2024 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $49.47 | 2020-2024 | |
| Sun Pharmaceutical Industries INC. | $49.44 | 2023 | Cequa |
| Optos, INC. | $41.40 | 2022 | |
| Allergan, INC. | $35.46 | 2022 | |
| The Cameron-Ehlen Group, INC. | $34.61 | 2022 | |
| Horizon Therapeutics Plc | $32.18 | 2023 | Tepezza |
| Sight Sciences, INC. | $23.26 | 2024 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $17.77 | 2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $15.97 | 2024 | Syfovre |
| Eyepoint US, INC. | $13.33 | 2020 | |
| Ocular Therapeutix, INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.